$0.000.00 |(%)
About IAM
- Industry:
- Exchange:
- Country:
Frequently Asked Questions
What is the 52-week range for IAM?
The 52-week high is $ and the 52-week low is $.
What is the P/E ratio for IAM?
The P/E ratio data is currently unavailable.
What is the dividend yield for IAM?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
ROE data is currently unavailable.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Latest IAM News
U.S. IPO Weekly Recap: Oura Postpones $2.1 Billion IPO And Accelevation Trades Off, Adding To Market Jitters
One sizable IPO, one direct listing, and one SPAC debuted this week. Read more here.
SeekingAlpha10/3/2026
U.S. IPO Weekly Recap: Postponed Deals Put Damper On Fall IPO Market
One IPO and two SPACs debuted this week, although more deals were originally on the calendar. Read more here.
SeekingAlpha9/25/2026
Iambic Therapeutics Starts IPO Effort On Broad Collaboration Relationships
Iambic Therapeutics has a wide range of collaboration partners for its technology platform and drug discovery and trial efforts. Read more on IAM here.
SeekingAlpha9/25/2026